Show
Sort by
-
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population
-
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial
-
Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051)
-
Targeted therapies in the treatment of advanced/metastatic NSCLC
-
Toxicity of EORTC 08031: phase 11 feasibility trial of induction chemotherapy (ICT) followed by extrapleural pneumonectomy (EPP) and postoperative radiotherapy (PORT) for malignant pleural mesothelioma (MPM) cT3N1M0 or less
-
A FACILE METHOD FOR THE ALPHA-MONOCHLORINATION OF ALDIMINES AND ALDEHYDES.